Bayesian Capital Management, LP Trans Medics Group, Inc. Transaction History
Bayesian Capital Management, LP
- $600 Million
- Q2 2025
A detailed history of Bayesian Capital Management, LP transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 6,200 shares of TMDX stock, worth $841,898. This represents 0.14% of its overall portfolio holdings.
Number of Shares
6,200
Previous 11,855
47.7%
Holding current value
$841,898
Previous $797,000
4.14%
% of portfolio
0.14%
Previous 0.14%
Shares
8 transactions
Others Institutions Holding TMDX
# of Institutions
421Shares Held
29.9MCall Options Held
1.19MPut Options Held
777K-
Vanguard Group Inc Valley Forge, PA3.6MShares$488 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$359 Million0.01% of portfolio
-
State Street Corp Boston, MA1.29MShares$175 Million0.01% of portfolio
-
Fil LTD Hamilton, D01.06MShares$143 Million0.13% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL956KShares$130 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $4.32B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...